¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"slow component of nystagmus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • slow phase
    Àú¼Ó±â
  • slow pulse
    ´À¸°¸Æ¹Ú, ¼­¸Æ
  • slow respiration
    ´À¸°È£Èí
  • slow sand filter
    ¿Ï¼Ó¸ð·¡¿©°ú±â, ´À¸°¸ð·¡°Å¸£°³
  • slow virus
    ½½·Î¿ì¹ÙÀÌ·¯½º
  • slow wave burst
    ´À¸°µ¹¹ßÆÄ
  • slow wave sleep
    ´À¸°ÆÄÇü¼ö¸é, ¼­ÆÄ¼ö¸é(ßï÷îâ²Øù)
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • asymmetric gaze nystagmus
    ºñ´ëĪÁֽô«¶³¸²
  • ataxic nystagmus
    ½ÇÁ¶¼º´«¶³¸², ¿îµ¿½ÇÁ¶´«¶³¸²
  • aural nystagmus
    À̼º¾ÈÁø, ±ÍÅ¿´«¶³¸²
  • abducting nystagmus
    °¡ÂÊ´«¶³¸², ¿ÜÀü¾ÈÁø
  • alternating nystagmus
    ±³´ë´«¶³¸², ±³´ë¾ÈÁø
  • amaurotic nystagmus
    Èæ¾Ï½Ã´«¶³¸²
  • amblyopic nystagmus
    ¾à½Ã´«¶³¸², ¾à½Ã¾ÈÁø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • slow sand filter
    ´À¸°¸ð·¡°Å¸£°³, ¿Ï¼Ó¸ð·¡¿©°ú±â
  • slow grower
    ´À¸°¹ßÀ°±Õ
  • slow induction
    ´À¸°¸¶ÃëÀ¯µµ
  • slow onset infection
    ´À¸°½ÃÀÛ°¨¿°
  • slow neutron
    Àú¼ÓÁß¼ºÀÚ
  • slow phase
    Àú¼Ó±â
  • slow pulse
    ´À¸°¸Æ¹Ú
  • slow respiration
    ´À¸°È£Èí
  • slow
    ´À¸°-, Àú¼Ó-
  • slow wave sleep
    (¢¡NREM sleep) ´À¸°´«¿îµ¿¼ö¸é, ºñ±Þ¼Ó¾È±¸¿îµ¿¼ö¸é
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • abducting nystagmus
    °¡ÂÊ´«¶³¸², ¿ÜÀü¾ÈÁø
  • alternating nystagmus
    ±³´ë´«¶³¸², ±³´ë¾ÈÁø
  • amaurotic nystagmus
    Èæ¾Ï½Ã´«¶³¸²
  • amblyopic nystagmus
    ¾à½Ã´«¶³¸², ¾à½Ã¾ÈÁø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amaurotic nystagmus
    Èæ¾Ï½Ã¾ÈÁø
  • amblyopic nystagmus
    ¾à½Ã¾ÈÁø
  • galvanic nystagmus
    Àü±â¾ÈÁø(¡­äÑòè).
  • gaze nystagmus
    ÁֽþÈÁø
  • gaze nystagmus test
    ÁֽþÈÁø°Ë»ç
  • gaze paretic nystagmus
    Áֽø¶ºñ¾ÈÁø
  • gaze paretic nystagmus
    Áֽø¶ºñ¼º¾ÈÁø
  • head nystagmus
    ¸Ó¸®ÁøÅÁ(¡­òè.J), µÎÁø (Ôéòè).
  • head nystagmus
    ¸Ó¸® ÁøÅÁ(¡­òè.J), µÎÁø(Ôéòè)
  • head nystagmus
    µÎÁø
  • horizontal nystagmus
    ¼öÆò¾ÈÁø.
  • horizontal nystagmus
    ¼öÆò¾ÈÁø
  • hysterical nystagmus
    È÷½ºÅ׸®¾ÈÁø
  • perverted nystagmus
    ÀÌ»ó¾ÈÁø
  • physiological nystagmus
    »ý¸®Àû ¾ÈÁø(ßæìµîÜ äÑòè)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • plasma thromboplastin component defic
    ÇöóÁ<Ç÷Àå>Æ®·Òº¸ÇÃ¶ó½ºÆ¾¼ººÐ°áÇÌ(Áõ
  • principal component
    ÁÖ¼ººÐ(ñ«à÷ÝÂ).
  • quick component
    ±Þ°Ý¼ººÐ(ÐáÌ­à÷ÝÂ).
  • secretory component
    ºÐºñ¼ººÐ
  • series elastic component
    Á÷·Äź·Â¼ººÐ(òÁ æê÷¥æ³à÷ÝÂ).
  • third component
    Á¦»ï¼ººÐ(ð¯ß²à÷ÝÂ).
  • thromboplastin plasma component
    Ç÷¼ÒÆÇ¼º Ç÷À强ºÐ(úìá³÷ùàõúìíìà÷ÝÂ).
  • chronic slow viral encephalitis
    ¸¸¼ºÁö¿¬Çü ¹ÙÀÌ·¯½º¼º ³ú¿°(¡­Òàæú).
  • encephalitis,slow virus disease
    ½½·Î¿ì ¹ÙÀÌ·¯½º º´
  • infection, slow virus
    Áö¹ß¹ÙÀÌ·¯½º°¨¿°
  • sharp and slow wave complex
    ¿¹¼­ÆÄº¹ÇÕ(çåßï÷îÜÜùê).
  • slow disease
    Áö¹ß (òÀÛ¡) Áúȯ
  • slow fever
    Áö¿¬¿­(òÀæÅæð).
  • slow fever
    Áö¿¬¿­(òÀæÅæð)
  • slow fiber
    ¿Ï¼­¼¶À¯(èÐßïàéë«).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BPPN benign paroxysmal positioning nystagmus
CN caudate nucleus; cellulose nitrate; charge nurse; child nutrition; chloroacetophenone; clinical nurs...
GN gaze nystagmus; glomerulonephritis; glucose nitrogen [ratio]; gnotobiote; graduate nurse; gram-negat...
MLN manifest latent nystagmus; membranous lupus nephropathy; mesenteric lymph node; motilin
MPPN malignant persistent positional nystagmus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OKAN Optokinetic after nystagmus
PAN Periodic alternating nystagmus
PR-N Postrotatory nystagmus
SN Spontaneous nystagmus
S R)/slow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • heavier inflammatory component
    ´õ ½ÉÇÑ ¿°Áõ ¿äÀÎ
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • motivational component
    µ¿±â ºÎ¿© ¿ä¼Ò
  • sensory component
    °¨°¢ ¿ä¼Ò
  • after-nystagmus
    ÈÄ¹ß ¾ÈÁø
  • amblyopic nystagmus
    ¾à½Ã ¾ÈÁø
  • aural nystagmus
    À̼º ¾ÈÁø
  • chene's nystagmus
    üÀÎ-½ºÅäÅ©½º ¾ÈÁø
  • circumduction nystagmus
    ¼øÈ¯ ¾ÈÁø
  • combined nystagmus
    º¹ÇÕ ¾ÈÁø
  • congenital nystagmus
    ¼±Ãµ¼º ¾ÈÁø
    ÁÖ½ÃÀÇ ¸ðµç À§Ä¡°¡ ¼öÆòÀÎ ÁøÀÚ¼º ¶Ç´Â À²µ¿¼º ¾ÈÁøÀ̸ç, ÆøÁÖ¿¡ ÀÇÇØ ¾àÈ­µÇ¸ç, ȯÀÚ´Â ¸Õ °Å¸®º¸´Ù °¡±î¿î °Å¸®¿¡¼­ ´õ Àß º»´Ù.
  • fixation nystagmus
    °í½Ã ¾ÈÁø
  • frequency of nystagmus
    ¾È ºóµµ
  • jerking nystagmus
    À²µ¿ ¾ÈÁø, À²µ¿¼º ¾ÈÁø
  • jerky nystagmus
    ¿îµ¿¼º ¾ÈÁø
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
amyloid p component Amyloid p component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It acts as an acute phase protein in the mouse, modulates immunologic responses in man, inhibits elastase, and has been suggested as an indicator of liver disease.
(12 Dec 1998)
anterior component of force A force operating to move teeth anteriorly.
(05 Mar 2000)
blood component removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.
(12 Dec 1998)
blood component transfusion The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in plasmapheresis and types of cytapheresis (plateletpheresis and leukapheresis) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.
(12 Dec 1998)
p18 component, aminoacyl tRNA synthetase <enzyme> Shares a protein motif with the beta and gamma subunits of eukaryotic elongation factor 1; amino acid sequence given in first source
Registry number: EC 6.1.1.-
Synonym: p18 aminoacyl-trna synthase
(26 Jun 1999)
granular component of nucleolus Area of nucleolus that appears granular in the electron microscope and contains 15nm diameter particles that are maturing ribosomes. In contrast to the pale staining and fibrillar areas.
(18 Nov 1997)
component <physiology> A constituent element or part, specifically in neurology, a series of neurons forming a functional system for conducting the afferent and efferent impulses in the somatic and splanchnic mechanisms of the body.
(05 Jan 1998)
component A, Rab geranylgeranyl transferase <chemical> Binds unprenylated rab1a and presents it to the catalytic component b; do not confuse with rep-1 from yeast; see also mrs6 protein
Synonym: rab escort protein, rab geranylgeranyltransferase component a, rep-1 protein, rab escort protein-1, choroideraemia gene product, chm gene product, mrs6 gene product
(26 Jun 1999)
component E, glutamate mutase <chemical> The large subunit of glutamate mutase; from clostridium tetanomorphum; has 485 amino acid residues; mw 53,708 da; has been sequenced
Synonym: mute gene product, clostridium, mute protein, clostridium
(26 Jun 1999)
component of complement Any one of the nine distinct protein units (designated C1 through C9 and distributed in the a, b, and g electrophoretic partitions of normal serum) that effect the immunological activities long associated with complement. C1 is a complex of three subunits: C1q, C1r, and C1s. C1q (overbar indicates "active form") activates proenzyme C1r to C1r which activates C1s to C1s (also known as C1 esterase), which converts proenzyme C2 to C2b and produces C4b from C4. C2b combines with C4b to form "classical-complement-pathway C3/C5 convertase" (also known as C3 convertase, C5 convertase, and C42). This enzyme cleaves C3 to C3a and C3b, and C5 to yield C5a and C5b, as does "alternative-complement-pathway C3/C5 convertase" (also known as proenzyme factor B, properdin factor B, C3 proactivator, and heat-labile factor). Complement factor I (also known as C3b or C3b/C4b inactivator) inactivates C3b and C4b by a different proteolytic cleavage. Several autosomal recessive disorders have been identified in which one or more of the complement components have been deficient or completely absent.
(05 Mar 2000)
component of force One of the factors from which a resultant force may be compounded or into which it may be resolved, one of the vectors into which a force may be resolved.
(05 Mar 2000)
component S, glutamate mutase <chemical> Component s of the coenzyme b12-dependent glutamate mutase from clostridium cochlearium; mw 15 kD; amino acid sequence given in first source
Synonym: glms gene product, muts gene product (clostridium)
(26 Jun 1999)
plasma thromboplastin component <chemical> Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. Deficiency of factor ix results in christmas disease (haemophilia b).
Chemical name: Blood-coagulation factor IX
(12 Dec 1998)
habitat component <ecology> A single element (for example, velocity, depth, cover, etc.) of the habitat or environment in which a fish or other aquatic species or population may live or occur.
(09 Oct 1997)
secretory component <physiology> A glycoprotein found in a variety of external secretions (tears, bile, colostrum) usually complexed to secreted polymeric immunoglobulins (IgA or, less frequently IgM).
It is derived, by proteolytic cleavage, from the polymeric immunoglobulin receptor (receptors, polymeric immunoglobulin) and probably functions to protect the immunoglobulins from proteolysis in the secretions.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á